40.00
price up icon0.88%   0.35
after-market アフターアワーズ: 40.00
loading
前日終値:
$39.65
開ける:
$39.64
24時間の取引高:
529.14K
Relative Volume:
0.91
時価総額:
$2.32B
収益:
$32.87M
当期純損益:
$674.31M
株価収益率:
3.5211
EPS:
11.36
ネットキャッシュフロー:
$-330.11M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+22.29%
6か月 パフォーマンス:
+16.08%
1年 パフォーマンス:
-17.53%
1日の値動き範囲:
Value
$38.82
$40.13
1週間の範囲:
Value
$38.48
$40.98
52週間の値動き範囲:
Value
$23.41
$62.58

Agios Pharmaceuticals Inc Stock (AGIO) Company Profile

Name
名前
Agios Pharmaceuticals Inc
Name
セクター
Healthcare (1164)
Name
電話
617-649-8600
Name
住所
88 SIDNEY STREET, CAMBRIDGE, MA
Name
職員
488
Name
Twitter
@AgiosPharma
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
AGIO's Discussions on Twitter

AGIO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
AGIO
Agios Pharmaceuticals Inc
40.00 2.30B 32.87M 674.31M -330.11M 11.36
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 122.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 31.91B 3.81B -644.79M -669.77M -6.24

Agios Pharmaceuticals Inc Stock (AGIO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-24 開始されました H.C. Wainwright Buy
2024-10-16 開始されました Scotiabank Sector Outperform
2024-10-10 再開されました Raymond James Outperform
2024-09-27 ダウングレード Leerink Partners Outperform → Market Perform
2024-02-08 開始されました Cantor Fitzgerald Overweight
2023-02-03 開始されました Piper Sandler Overweight
2022-11-17 アップグレード Goldman Sell → Neutral
2022-07-27 アップグレード SVB Leerink Mkt Perform → Outperform
2021-12-03 開始されました BofA Securities Buy
2021-07-30 ダウングレード Goldman Neutral → Sell
2021-07-01 開始されました Raymond James Mkt Perform
2021-06-10 開始されました H.C. Wainwright Buy
2021-03-01 ダウングレード JP Morgan Overweight → Neutral
2021-03-01 アップグレード SVB Leerink Mkt Perform → Outperform
2021-02-26 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-10-22 アップグレード Barclays Equal Weight → Overweight
2020-03-04 開始されました Barclays Equal Weight
2019-11-26 開始されました Cantor Fitzgerald Overweight
2019-09-23 アップグレード Guggenheim Neutral → Buy
2019-05-23 再開されました Goldman Neutral
2019-02-15 アップグレード SVB Leerink Mkt Perform → Outperform
2018-09-25 開始されました Leerink Partners Mkt Perform
2018-05-23 開始されました Citigroup Buy
2018-04-11 繰り返されました Credit Suisse Outperform
2018-02-15 繰り返されました Needham Buy
2018-02-15 繰り返されました SunTrust Buy
2017-09-15 開始されました RBC Capital Mkts Outperform
2017-08-10 繰り返されました Needham Buy
2017-08-08 繰り返されました SunTrust Buy
2017-08-02 アップグレード Leerink Partners Mkt Perform → Outperform
2017-06-26 ダウングレード Janney Buy → Neutral
2017-01-17 アップグレード Oppenheimer Perform → Outperform
2016-10-24 開始されました Needham Buy
2016-06-13 アップグレード JP Morgan Neutral → Overweight
2016-05-18 繰り返されました SunTrust Buy
すべてを表示

Agios Pharmaceuticals Inc (AGIO) 最新ニュース

pulisher
04:28 AM

What risks could impact Agios Pharmaceuticals Inc. stock performanceFree Stock Market Trend Analysis - jammulinksnews.com

04:28 AM
pulisher
12:24 PM

Is Agios Pharmaceuticals Inc. a good long term investmentTremendous financial leverage - Autocar Professional

12:24 PM
pulisher
Jul 24, 2025

Will Agios Pharmaceuticals Inc. stock split in the near futureJaw-dropping returns - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

When the Price of (AGIO) Talks, People Listen - news.stocktradersdaily.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Agios Pharmaceuticals Inc. stock priceTriple-digit returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

BlackRock, Inc. Reduces Stake in Agios Pharmaceuticals Inc - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Agios Pharmaceuticals Inc. Stock Analysis and ForecastFree Smart Trading Workshop - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Agios Pharmaceuticals Inc. stockFree Consultation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Lobbying Update: $20,000 of AGIOS PHARMACEUTICALS lobbying was just disclosed - Quiver Quantitative

Jul 22, 2025
pulisher
Jul 22, 2025

Agios Pharmaceuticals (AGIO): Analyst Maintains Buy Rating, Lowe - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

Agios Pharmaceuticals (AGIO): BofA Adjusts Price Target Amid Rev - GuruFocus

Jul 22, 2025
pulisher
Jul 21, 2025

Agios Pharmaceuticals (AGIO) Moves 7.7% Higher: Will This Strength Last? - MSN

Jul 21, 2025
pulisher
Jul 18, 2025

What makes Agios Pharmaceuticals Inc. stock attractive to long term investorsLow Risk Entry Points - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Is Agios Pharmaceuticals Inc. stock a growth or value playFree Daily Stock Market Updates - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Teacher Retirement System of Texas Lowers Stock Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - Defense World

Jul 18, 2025
pulisher
Jul 15, 2025

why agios pharmaceuticals inc. stock attracts strong analyst attentionSafe High Return Entry Points - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Agios Pharmaceuticals Inc. stock price move sharplyDaily Gain Forecast - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Agios Pharmaceuticals to Host Conference Call on Second Quarter 2025 Financial Results and Business Highlights - Nasdaq

Jul 14, 2025
pulisher
Jul 14, 2025

Rare Disease Leader Agios Sets Q2 Earnings Call: Key Updates Expected on PK Activation Therapies - Stock Titan

Jul 14, 2025
pulisher
Jul 14, 2025

Public market insider buying at Extendicare (EXE) - The Globe and Mail

Jul 14, 2025
pulisher
Jul 14, 2025

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Insider Sells $452,612.86 in Stock - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

FY2025 Earnings Estimate for AGIO Issued By Zacks Research - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Trend Tracker for (AGIO) - news.stocktradersdaily.com

Jul 14, 2025
pulisher
Jul 11, 2025

Agios pharma chief medical officer Gheuens sells $452,601 in stock By Investing.com - Investing.com Canada

Jul 11, 2025
pulisher
Jul 09, 2025

Agios Pharmaceuticals Inc. (AGIO) Shares Soar 7.69% on FDA Designation - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Agios Pharma Appoints Dr. Jay Backstrom as Director - The Globe and Mail

Jul 09, 2025
pulisher
Jul 09, 2025

Agios Pharmaceuticals appoints Jay Backstrom to board of directors By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 08, 2025

Agios Pharmaceuticals shares rise 3.64% intraday after appointing Dr. Jay Backstrom to its Board of Directors. - AInvest

Jul 08, 2025
pulisher
Jul 08, 2025

Agios Appoints Dr. Jay Backstrom To Board - citybiz

Jul 08, 2025
pulisher
Jul 08, 2025

Agios appoints Dr. Jay Backstrom to board of directors - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Agios Appoints Dr. Jay Backstrom to Board of Directors - The Manila Times

Jul 08, 2025
pulisher
Jul 08, 2025

Agios Pharmaceuticals Appoints Dr. Jay Backstrom to Board of Directors - Quiver Quantitative

Jul 08, 2025
pulisher
Jul 08, 2025

Agios Appoints Dr. Jay Backstrom to Board of Directors | AGIO St - GuruFocus

Jul 08, 2025
pulisher
Jul 07, 2025

H.C. Wainwright Maintains a Buy Rating on Agios Pharmaceuticals (AGIO), Reduces PT - MSN

Jul 07, 2025
pulisher
Jun 30, 2025

Agios Pharmaceuticals, Inc.(NasdaqGS: AGIO) added to Russell 2000 Defensive Index - MarketScreener

Jun 30, 2025
pulisher
Jun 26, 2025

Agios pharma chief legal officer Burns sells $93k in stock - Investing.com

Jun 26, 2025
pulisher
Jun 18, 2025

Agios Pharmaceuticals, Inc. (AGIO) Backed by TD Cowen for Mitapivat’s Market Potential - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Agios Pharma Increases Shares in Stock Incentive Plan - TipRanks

Jun 18, 2025

Agios Pharmaceuticals Inc (AGIO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Agios Pharmaceuticals Inc (AGIO) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Scadden David
Director
Jul 10 '25
Sale
40.00
1,400
56,000
17,603
Gheuens Sarah
Chief Medical Officer
Jul 09 '25
Option Exercise
25.01
11,914
297,969
73,185
Gheuens Sarah
Chief Medical Officer
Jul 09 '25
Sale
37.99
11,914
452,601
61,271
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):